Ad comm meeting approaches for Durata drug

|About: Durata Therapeutics (DRTX)|By:, SA News Editor

Anti-Infective Drugs Advisory Committee meets on Monday to review Durata Therapeutics' (DRTX) antibacterial Dalvance (dalbavancin) NDA.

PDUFA date is May 26.

Consensus total revenue estimates for 2014 and 2015 are $16.3M and $67.2M, respectively.

Meeting materials.